Clinical observation of pemetrexed on advanced non-small-cell lung cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10330-011-0757-z.pdf
Reference16 articles.
1. Demarinis F, Paul S, Hanna N, et al. Survival update for the phase III study of pemetrexed vs. docetaxel in non-small cell lung cancer (NSCLC). J Clin Oncol, 2006, 24: 397–397.
2. Hanan N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previous treated with chemotherapy. J Clin Oncol, 2004, 22:1589–1597.
3. Scagliotti GV, Parikh P, Von PJ, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol, 2008, 26: 3543–3551.
4. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst, 2000, 92: 205–216.
5. Sun Y. Medical oncology. Beijing: People Health Press, 2001. 324–340.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Jinshuixian in combination with radiotherapy suppresses the proliferation of A549 cells by inhibiting the expression of VEGF;The Chinese-German Journal of Clinical Oncology;2013-09
2. The current situation of Sunitinib in treating non-small cell lung cancer;The Chinese-German Journal of Clinical Oncology;2012-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3